butylscopolammonium bromide has been researched along with cimetropium in 5 studies
| Studies (butylscopolammonium bromide) | Trials (butylscopolammonium bromide) | Recent Studies (post-2010) (butylscopolammonium bromide) | Studies (cimetropium) | Trials (cimetropium) | Recent Studies (post-2010) (cimetropium) |
|---|---|---|---|---|---|
| 695 | 165 | 149 | 46 | 20 | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barzaghi, F; Bonetti, C; Cesana, R; Fortin, M; Galliani, G; Hunt, P; Maggioni, A; Nencioni, A; Parini, C; Toja, E | 1 |
| Hata, F; Nishio, H; Saitoh, N; Takeuchi, T | 1 |
| Aoki, S; Iwamoto, M; Jino, H; Kawaguchi, A; Kitagawa, H; Kurahashi, K; Nishiwaki, H; Usui, H | 1 |
| Ikoma, F; Itatani, H; Kishimoto, T; Koide, T; Kurita, T; Morimoto, S; Ogawa, N; Ohkawa, T; Okuyama, A; Yoshioka, T | 1 |
| Evangelista, S | 1 |
1 review(s) available for butylscopolammonium bromide and cimetropium
| Article | Year |
|---|---|
Quaternary ammonium derivatives as spasmolytics for irritable bowel syndrome.
Topics: Butylscopolammonium Bromide; Clinical Trials as Topic; Humans; Irritable Bowel Syndrome; Morpholines; Parasympatholytics; Quaternary Ammonium Compounds; Scopolamine Derivatives; Structure-Activity Relationship | 2004 |
1 trial(s) available for butylscopolammonium bromide and cimetropium
| Article | Year |
|---|---|
[Clinical phase III study of cimetropium bromide (DA3177) on the pain with upper urinary calculus: a double-blind study in comparison with scopolamine butylbromide. DA3177 Study Group].
Topics: Adult; Aged; Butylscopolammonium Bromide; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Pain; Parasympatholytics; Scopolamine Derivatives; Urinary Calculi | 1997 |
3 other study(ies) available for butylscopolammonium bromide and cimetropium
| Article | Year |
|---|---|
New classes of antimuscarinic agents endowed with selective antispasmodic properties. 1-Arylsulfonyl pyrrolidin-2-ones and 2-thiones, 1-arylsulfonyl piperidin-2-ones and 2-thiones and 1-arylsulfonyl hexahydro-2H-azepin-2-one.
Topics: Animals; Arecoline; Atropine; Azepines; Butylscopolammonium Bromide; Carbachol; Gastric Acid; Gastrointestinal Motility; Guinea Pigs; In Vitro Techniques; Male; Mice; Muscle Contraction; Muscle, Smooth; Parasympatholytics; Piperidines; Pupil; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Scopolamine Derivatives; Sulfones | 1994 |
Characterization of antimuscarinic effect of cimetropium bromide in guinea pig ileum.
Topics: Acetylcholine; Animals; Atropine; Butylscopolammonium Bromide; Choline; Electric Stimulation; Guinea Pigs; Ileum; In Vitro Techniques; Male; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Myenteric Plexus; Nerve Endings; Nicotine; Scopolamine Derivatives | 1997 |
Inhibitory effects of various spasmolytics on the vagal afferent gastric excitatory response in cats.
Topics: Animals; Atropine; Butylscopolammonium Bromide; Cats; Electric Stimulation; Female; Male; Neurons, Afferent; Neurons, Efferent; Parasympatholytics; Pirenzepine; Scopolamine Derivatives; Stomach; Vagus Nerve | 1997 |